Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5]
- 1 January 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (1), 186-190
- https://doi.org/10.1016/j.bmcl.2005.09.031
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter StudyClinical Infectious Diseases, 2001
- Pharmacology of ItraconazoleDrugs, 2001
- Voriconazole: A New Triazole AntifungalAnnals of Pharmacotherapy, 2000
- Efficacy of Liposomal Amphotericin B with Prolonged Circulation in Blood in Treatment of Severe Pulmonary Aspergillosis in Leukopenic RatsAntimicrobial Agents and Chemotherapy, 2000
- National Epidemiology of Mycoses Survey (NEMIS): Variations in Rates of Bloodstream Infections Due to Candida Species in Seven Surgical Intensive Care Units and Six Neonatal Intensive Care UnitsClinical Infectious Diseases, 1999
- Itraconazole in Cyclodextrin SolutionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)Clinical Infectious Diseases, 1999
- Nosocomial infections in coronary care units in the United StatesThe American Journal of Cardiology, 1998
- Enhanced Bioavailability of Itraconazole in Hydroxypropylβ-Cyclodextrin Solution versus Capsules in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 1998
- Long-Circulating Immunoliposomal Amphotericin B against Invasive Pulmonary Aspergillosis in MiceAntimicrobial Agents and Chemotherapy, 1998